This Cochrane Group is no longer active

Due to changes in NIHR funding in evidence synthesis, this Cochrane Group is no longer active. We are so grateful for the work of our contributors.

If you would like to get involved with Cochrane, please visit our Join Cochrane pages.

To learn more about Cochrane, visit our homepage.

If you would like to propose a topic for a Cochrane Review, please see our instructions for authors.

If you have any queries, please contact Cochrane Support.

Cochrane Neuromuscular

MRC Centre for Neuromuscular Diseases, Queen Square


Cochrane Neuromuscular was registered as a Cochrane Review Group in March 1998. Since September 2008 the group has been based in the Queen Square Centre for Neuromuscular Diseases within the National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust.

We aim to provide systematic reviews of interventions for all neuromuscular diseases, including amyotrophic lateral sclerosis (which is also known as motor neuron disease), peripheral nerve disorders, myasthenia gravis and neuromuscular function disorders, and muscle diseases. We also have a small number of diagnostic test accuracy reviews in progress.

Cochrane Neuromuscular is part of Cochrane, an independent not-for-profit international collaboration dedicated to providing up-to-date, accurate information about the effects of health care.

The National Institute for Health Research (NIHR) is the largest single funder of this Cochrane Review Group. The group receives additional support from the Queen Square Centre for Neuromuscular Diseases and the MND Association (UK).

Our membership has risen to over 900 researchers, healthcare professionals and consumers from around the world. Anyone interested in contributing to the work of the Group is invited to contact the Managing Editor at